nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—CYP2C19—Progesterone—uterine cancer	0.16	0.265	CbGbCtD
Meprobamate—ABCB1—Progesterone—uterine cancer	0.129	0.214	CbGbCtD
Meprobamate—CYP2E1—Etoposide—uterine cancer	0.114	0.189	CbGbCtD
Meprobamate—ABCB1—Dactinomycin—uterine cancer	0.102	0.17	CbGbCtD
Meprobamate—ABCB1—Etoposide—uterine cancer	0.0577	0.0958	CbGbCtD
Meprobamate—ABCB1—Doxorubicin—uterine cancer	0.0393	0.0653	CbGbCtD
Meprobamate—Proctitis—Dactinomycin—uterine cancer	0.0205	0.0515	CcSEcCtD
Meprobamate—Hyperpyrexia—Medroxyprogesterone Acetate—uterine cancer	0.0172	0.0433	CcSEcCtD
Meprobamate—Slurred speech—Progesterone—uterine cancer	0.0158	0.0398	CcSEcCtD
Meprobamate—Proctitis—Epirubicin—uterine cancer	0.00832	0.0209	CcSEcCtD
Meprobamate—Proctitis—Doxorubicin—uterine cancer	0.0077	0.0193	CcSEcCtD
Meprobamate—Dysarthria—Progesterone—uterine cancer	0.00749	0.0188	CcSEcCtD
Meprobamate—Dysarthria—Medroxyprogesterone Acetate—uterine cancer	0.00679	0.017	CcSEcCtD
Meprobamate—Lymphadenopathy—Progesterone—uterine cancer	0.00603	0.0151	CcSEcCtD
Meprobamate—Anuria—Epirubicin—uterine cancer	0.00581	0.0146	CcSEcCtD
Meprobamate—Vascular purpura—Progesterone—uterine cancer	0.00575	0.0144	CcSEcCtD
Meprobamate—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00551	0.0138	CcSEcCtD
Meprobamate—Anuria—Doxorubicin—uterine cancer	0.00538	0.0135	CcSEcCtD
Meprobamate—Purpura—Progesterone—uterine cancer	0.00533	0.0134	CcSEcCtD
Meprobamate—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00483	0.0121	CcSEcCtD
Meprobamate—Aplastic anaemia—Dactinomycin—uterine cancer	0.0047	0.0118	CcSEcCtD
Meprobamate—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00438	0.011	CcSEcCtD
Meprobamate—Drowsiness—Progesterone—uterine cancer	0.00396	0.00995	CcSEcCtD
Meprobamate—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.00396	0.00995	CcSEcCtD
Meprobamate—Body temperature increased—Carboplatin—uterine cancer	0.0038	0.00955	CcSEcCtD
Meprobamate—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00359	0.00902	CcSEcCtD
Meprobamate—Oedema peripheral—Progesterone—uterine cancer	0.0035	0.0088	CcSEcCtD
Meprobamate—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.0035	0.00879	CcSEcCtD
Meprobamate—Erythema multiforme—Progesterone—uterine cancer	0.00336	0.00845	CcSEcCtD
Meprobamate—Rash maculo-papular—Etoposide—uterine cancer	0.00329	0.00827	CcSEcCtD
Meprobamate—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00318	0.00797	CcSEcCtD
Meprobamate—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00305	0.00765	CcSEcCtD
Meprobamate—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00289	0.00726	CcSEcCtD
Meprobamate—Angioedema—Progesterone—uterine cancer	0.00283	0.0071	CcSEcCtD
Meprobamate—Vertigo—Progesterone—uterine cancer	0.00278	0.00699	CcSEcCtD
Meprobamate—Syncope—Progesterone—uterine cancer	0.00278	0.00697	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00278	0.00697	CcSEcCtD
Meprobamate—Palpitations—Progesterone—uterine cancer	0.00274	0.00687	CcSEcCtD
Meprobamate—Stomatitis—Dactinomycin—uterine cancer	0.00273	0.00685	CcSEcCtD
Meprobamate—Loss of consciousness—Progesterone—uterine cancer	0.00272	0.00683	CcSEcCtD
Meprobamate—Agranulocytosis—Dactinomycin—uterine cancer	0.00261	0.00656	CcSEcCtD
Meprobamate—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00647	CcSEcCtD
Meprobamate—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00256	0.00644	CcSEcCtD
Meprobamate—Anaphylactic shock—Progesterone—uterine cancer	0.00253	0.00635	CcSEcCtD
Meprobamate—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00633	CcSEcCtD
Meprobamate—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00632	CcSEcCtD
Meprobamate—Shock—Progesterone—uterine cancer	0.00249	0.00624	CcSEcCtD
Meprobamate—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00248	0.00623	CcSEcCtD
Meprobamate—Petechiae—Epirubicin—uterine cancer	0.00247	0.0062	CcSEcCtD
Meprobamate—Tachycardia—Progesterone—uterine cancer	0.00247	0.00619	CcSEcCtD
Meprobamate—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00247	0.00619	CcSEcCtD
Meprobamate—Erythema multiforme—Dactinomycin—uterine cancer	0.00238	0.00597	CcSEcCtD
Meprobamate—Hypotension—Progesterone—uterine cancer	0.00236	0.00593	CcSEcCtD
Meprobamate—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00229	0.00575	CcSEcCtD
Meprobamate—Petechiae—Doxorubicin—uterine cancer	0.00228	0.00574	CcSEcCtD
Meprobamate—Paraesthesia—Progesterone—uterine cancer	0.00227	0.0057	CcSEcCtD
Meprobamate—Chills—Dactinomycin—uterine cancer	0.00226	0.00566	CcSEcCtD
Meprobamate—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.00566	CcSEcCtD
Meprobamate—Somnolence—Progesterone—uterine cancer	0.00225	0.00564	CcSEcCtD
Meprobamate—Bronchospasm—Etoposide—uterine cancer	0.00224	0.00561	CcSEcCtD
Meprobamate—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.00561	CcSEcCtD
Meprobamate—Oliguria—Epirubicin—uterine cancer	0.0022	0.00553	CcSEcCtD
Meprobamate—Dysarthria—Epirubicin—uterine cancer	0.00215	0.00539	CcSEcCtD
Meprobamate—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00214	0.00537	CcSEcCtD
Meprobamate—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00516	CcSEcCtD
Meprobamate—Oliguria—Doxorubicin—uterine cancer	0.00204	0.00512	CcSEcCtD
Meprobamate—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00511	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00201	0.00505	CcSEcCtD
Meprobamate—Body temperature increased—Progesterone—uterine cancer	0.002	0.00502	CcSEcCtD
Meprobamate—Dysarthria—Doxorubicin—uterine cancer	0.00199	0.00499	CcSEcCtD
Meprobamate—Stomatitis—Etoposide—uterine cancer	0.00198	0.00496	CcSEcCtD
Meprobamate—Leukopenia—Dactinomycin—uterine cancer	0.00196	0.00492	CcSEcCtD
Meprobamate—Aplastic anaemia—Epirubicin—uterine cancer	0.00191	0.00479	CcSEcCtD
Meprobamate—Agranulocytosis—Etoposide—uterine cancer	0.00189	0.00475	CcSEcCtD
Meprobamate—Hypersensitivity—Progesterone—uterine cancer	0.00186	0.00468	CcSEcCtD
Meprobamate—Rash maculo-papular—Epirubicin—uterine cancer	0.00185	0.00464	CcSEcCtD
Meprobamate—Ecchymosis—Epirubicin—uterine cancer	0.00184	0.00461	CcSEcCtD
Meprobamate—Asthenia—Progesterone—uterine cancer	0.00181	0.00455	CcSEcCtD
Meprobamate—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00455	CcSEcCtD
Meprobamate—Pruritus—Progesterone—uterine cancer	0.00179	0.00449	CcSEcCtD
Meprobamate—Aplastic anaemia—Doxorubicin—uterine cancer	0.00176	0.00443	CcSEcCtD
Meprobamate—Diarrhoea—Progesterone—uterine cancer	0.00173	0.00434	CcSEcCtD
Meprobamate—Lymphadenopathy—Epirubicin—uterine cancer	0.00173	0.00434	CcSEcCtD
Meprobamate—Erythema multiforme—Etoposide—uterine cancer	0.00172	0.00432	CcSEcCtD
Meprobamate—Rash maculo-papular—Doxorubicin—uterine cancer	0.00171	0.00429	CcSEcCtD
Meprobamate—Ecchymosis—Doxorubicin—uterine cancer	0.0017	0.00427	CcSEcCtD
Meprobamate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00424	CcSEcCtD
Meprobamate—Dizziness—Progesterone—uterine cancer	0.00167	0.0042	CcSEcCtD
Meprobamate—Vascular purpura—Epirubicin—uterine cancer	0.00165	0.00414	CcSEcCtD
Meprobamate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00413	CcSEcCtD
Meprobamate—Chills—Etoposide—uterine cancer	0.00163	0.0041	CcSEcCtD
Meprobamate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00407	CcSEcCtD
Meprobamate—Vomiting—Progesterone—uterine cancer	0.00161	0.00403	CcSEcCtD
Meprobamate—Lymphadenopathy—Doxorubicin—uterine cancer	0.0016	0.00402	CcSEcCtD
Meprobamate—Dermatitis—Progesterone—uterine cancer	0.00159	0.004	CcSEcCtD
Meprobamate—Headache—Progesterone—uterine cancer	0.00158	0.00398	CcSEcCtD
Meprobamate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00393	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00156	0.00392	CcSEcCtD
Meprobamate—Dermatitis bullous—Epirubicin—uterine cancer	0.00154	0.00387	CcSEcCtD
Meprobamate—Purpura—Epirubicin—uterine cancer	0.00153	0.00384	CcSEcCtD
Meprobamate—Vascular purpura—Doxorubicin—uterine cancer	0.00152	0.00383	CcSEcCtD
Meprobamate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.0038	CcSEcCtD
Meprobamate—Nausea—Progesterone—uterine cancer	0.0015	0.00377	CcSEcCtD
Meprobamate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00366	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00145	0.00363	CcSEcCtD
Meprobamate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00362	CcSEcCtD
Meprobamate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.0036	CcSEcCtD
Meprobamate—Dermatitis bullous—Doxorubicin—uterine cancer	0.00143	0.00358	CcSEcCtD
Meprobamate—Vertigo—Etoposide—uterine cancer	0.00142	0.00357	CcSEcCtD
Meprobamate—Leukopenia—Etoposide—uterine cancer	0.00142	0.00356	CcSEcCtD
Meprobamate—Purpura—Doxorubicin—uterine cancer	0.00142	0.00355	CcSEcCtD
Meprobamate—Body temperature increased—Dactinomycin—uterine cancer	0.00141	0.00355	CcSEcCtD
Meprobamate—Loss of consciousness—Etoposide—uterine cancer	0.00139	0.0035	CcSEcCtD
Meprobamate—Ataxia—Epirubicin—uterine cancer	0.00139	0.00348	CcSEcCtD
Meprobamate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00342	CcSEcCtD
Meprobamate—Hypersensitivity—Dactinomycin—uterine cancer	0.00132	0.0033	CcSEcCtD
Meprobamate—Anaphylactic shock—Etoposide—uterine cancer	0.00129	0.00325	CcSEcCtD
Meprobamate—Ataxia—Doxorubicin—uterine cancer	0.00128	0.00322	CcSEcCtD
Meprobamate—Asthenia—Dactinomycin—uterine cancer	0.00128	0.00322	CcSEcCtD
Meprobamate—Tachycardia—Etoposide—uterine cancer	0.00126	0.00317	CcSEcCtD
Meprobamate—Eosinophilia—Epirubicin—uterine cancer	0.00126	0.00317	CcSEcCtD
Meprobamate—Diarrhoea—Dactinomycin—uterine cancer	0.00122	0.00307	CcSEcCtD
Meprobamate—Hypotension—Etoposide—uterine cancer	0.00121	0.00303	CcSEcCtD
Meprobamate—Eosinophilia—Doxorubicin—uterine cancer	0.00117	0.00293	CcSEcCtD
Meprobamate—Paraesthesia—Etoposide—uterine cancer	0.00116	0.00291	CcSEcCtD
Meprobamate—Somnolence—Etoposide—uterine cancer	0.00115	0.00289	CcSEcCtD
Meprobamate—Drowsiness—Epirubicin—uterine cancer	0.00114	0.00285	CcSEcCtD
Meprobamate—Vomiting—Dactinomycin—uterine cancer	0.00114	0.00285	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00113	0.00283	CcSEcCtD
Meprobamate—Stomatitis—Epirubicin—uterine cancer	0.00111	0.00278	CcSEcCtD
Meprobamate—Nausea—Dactinomycin—uterine cancer	0.00106	0.00266	CcSEcCtD
Meprobamate—Agranulocytosis—Epirubicin—uterine cancer	0.00106	0.00266	CcSEcCtD
Meprobamate—Drowsiness—Doxorubicin—uterine cancer	0.00105	0.00264	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00104	0.00262	CcSEcCtD
Meprobamate—Stomatitis—Doxorubicin—uterine cancer	0.00102	0.00257	CcSEcCtD
Meprobamate—Body temperature increased—Etoposide—uterine cancer	0.00102	0.00257	CcSEcCtD
Meprobamate—Oedema peripheral—Epirubicin—uterine cancer	0.001	0.00252	CcSEcCtD
Meprobamate—Agranulocytosis—Doxorubicin—uterine cancer	0.000981	0.00246	CcSEcCtD
Meprobamate—Erythema multiforme—Epirubicin—uterine cancer	0.000964	0.00242	CcSEcCtD
Meprobamate—Hypersensitivity—Etoposide—uterine cancer	0.000952	0.00239	CcSEcCtD
Meprobamate—Oedema peripheral—Doxorubicin—uterine cancer	0.00093	0.00233	CcSEcCtD
Meprobamate—Asthenia—Etoposide—uterine cancer	0.000928	0.00233	CcSEcCtD
Meprobamate—Chills—Epirubicin—uterine cancer	0.000915	0.0023	CcSEcCtD
Meprobamate—Pruritus—Etoposide—uterine cancer	0.000915	0.0023	CcSEcCtD
Meprobamate—Arrhythmia—Epirubicin—uterine cancer	0.000911	0.00229	CcSEcCtD
Meprobamate—Erythema multiforme—Doxorubicin—uterine cancer	0.000892	0.00224	CcSEcCtD
Meprobamate—Diarrhoea—Etoposide—uterine cancer	0.000884	0.00222	CcSEcCtD
Meprobamate—Dizziness—Etoposide—uterine cancer	0.000855	0.00215	CcSEcCtD
Meprobamate—Chills—Doxorubicin—uterine cancer	0.000847	0.00213	CcSEcCtD
Meprobamate—Arrhythmia—Doxorubicin—uterine cancer	0.000843	0.00212	CcSEcCtD
Meprobamate—Vomiting—Etoposide—uterine cancer	0.000822	0.00206	CcSEcCtD
Meprobamate—Agitation—Epirubicin—uterine cancer	0.000816	0.00205	CcSEcCtD
Meprobamate—Dermatitis—Etoposide—uterine cancer	0.000814	0.00204	CcSEcCtD
Meprobamate—Headache—Etoposide—uterine cancer	0.00081	0.00203	CcSEcCtD
Meprobamate—Vertigo—Epirubicin—uterine cancer	0.000798	0.002	CcSEcCtD
Meprobamate—Syncope—Epirubicin—uterine cancer	0.000796	0.002	CcSEcCtD
Meprobamate—Leukopenia—Epirubicin—uterine cancer	0.000795	0.002	CcSEcCtD
Meprobamate—Palpitations—Epirubicin—uterine cancer	0.000785	0.00197	CcSEcCtD
Meprobamate—Loss of consciousness—Epirubicin—uterine cancer	0.00078	0.00196	CcSEcCtD
Meprobamate—Nausea—Etoposide—uterine cancer	0.000768	0.00193	CcSEcCtD
Meprobamate—Agitation—Doxorubicin—uterine cancer	0.000755	0.0019	CcSEcCtD
Meprobamate—Vertigo—Doxorubicin—uterine cancer	0.000738	0.00185	CcSEcCtD
Meprobamate—Syncope—Doxorubicin—uterine cancer	0.000737	0.00185	CcSEcCtD
Meprobamate—Leukopenia—Doxorubicin—uterine cancer	0.000735	0.00185	CcSEcCtD
Meprobamate—Palpitations—Doxorubicin—uterine cancer	0.000726	0.00182	CcSEcCtD
Meprobamate—Anaphylactic shock—Epirubicin—uterine cancer	0.000725	0.00182	CcSEcCtD
Meprobamate—Loss of consciousness—Doxorubicin—uterine cancer	0.000722	0.00181	CcSEcCtD
Meprobamate—Shock—Epirubicin—uterine cancer	0.000713	0.00179	CcSEcCtD
Meprobamate—Tachycardia—Epirubicin—uterine cancer	0.000707	0.00178	CcSEcCtD
Meprobamate—Hypotension—Epirubicin—uterine cancer	0.000677	0.0017	CcSEcCtD
Meprobamate—Anaphylactic shock—Doxorubicin—uterine cancer	0.00067	0.00168	CcSEcCtD
Meprobamate—Shock—Doxorubicin—uterine cancer	0.00066	0.00166	CcSEcCtD
Meprobamate—Tachycardia—Doxorubicin—uterine cancer	0.000654	0.00164	CcSEcCtD
Meprobamate—Paraesthesia—Epirubicin—uterine cancer	0.000651	0.00163	CcSEcCtD
Meprobamate—Somnolence—Epirubicin—uterine cancer	0.000644	0.00162	CcSEcCtD
Meprobamate—Hypotension—Doxorubicin—uterine cancer	0.000627	0.00157	CcSEcCtD
Meprobamate—Paraesthesia—Doxorubicin—uterine cancer	0.000602	0.00151	CcSEcCtD
Meprobamate—Somnolence—Doxorubicin—uterine cancer	0.000596	0.0015	CcSEcCtD
Meprobamate—Body temperature increased—Epirubicin—uterine cancer	0.000573	0.00144	CcSEcCtD
Meprobamate—Hypersensitivity—Epirubicin—uterine cancer	0.000534	0.00134	CcSEcCtD
Meprobamate—Body temperature increased—Doxorubicin—uterine cancer	0.00053	0.00133	CcSEcCtD
Meprobamate—Asthenia—Epirubicin—uterine cancer	0.00052	0.00131	CcSEcCtD
Meprobamate—Pruritus—Epirubicin—uterine cancer	0.000513	0.00129	CcSEcCtD
Meprobamate—Diarrhoea—Epirubicin—uterine cancer	0.000496	0.00125	CcSEcCtD
Meprobamate—Hypersensitivity—Doxorubicin—uterine cancer	0.000494	0.00124	CcSEcCtD
Meprobamate—Asthenia—Doxorubicin—uterine cancer	0.000481	0.00121	CcSEcCtD
Meprobamate—Dizziness—Epirubicin—uterine cancer	0.000479	0.0012	CcSEcCtD
Meprobamate—Pruritus—Doxorubicin—uterine cancer	0.000474	0.00119	CcSEcCtD
Meprobamate—Vomiting—Epirubicin—uterine cancer	0.000461	0.00116	CcSEcCtD
Meprobamate—Diarrhoea—Doxorubicin—uterine cancer	0.000459	0.00115	CcSEcCtD
Meprobamate—Dermatitis—Epirubicin—uterine cancer	0.000456	0.00115	CcSEcCtD
Meprobamate—Headache—Epirubicin—uterine cancer	0.000454	0.00114	CcSEcCtD
Meprobamate—Dizziness—Doxorubicin—uterine cancer	0.000443	0.00111	CcSEcCtD
Meprobamate—Nausea—Epirubicin—uterine cancer	0.00043	0.00108	CcSEcCtD
Meprobamate—Vomiting—Doxorubicin—uterine cancer	0.000426	0.00107	CcSEcCtD
Meprobamate—Dermatitis—Doxorubicin—uterine cancer	0.000422	0.00106	CcSEcCtD
Meprobamate—Headache—Doxorubicin—uterine cancer	0.00042	0.00105	CcSEcCtD
Meprobamate—Nausea—Doxorubicin—uterine cancer	0.000398	0.001	CcSEcCtD
